DCM
CNCE

Driehaus Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Driehaus Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-44,016
Closed -$653K – 544
2018
Q3 		$653K Sell
44,016
-26,115
-37% -$411K 0.02% 387
2018
Q2 		$1.18M Sell
70,131
-29,869
-30% -$580K 0.04% 328
2018
Q1 		$2.29M Hold
100,000
– – 0.08% 241
2017
Q4 		$2.59M Sell
100,000
-162,569
-62% -$3.27M 0.1% 236
2017
Q3 		$3.87M Sell
262,569
-225,716
-46% -$3.28M 0.15% 183
2017
Q2 		$6.81M Buy
488,285
+57,303
+13% +$845K 0.25% 91
2017
Q1 		$7.35M Buy
+430,982
New +$5.17M 0.25% 89

Other funds holding CNCE

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return